Facilitators and Barriers Affecting Adherence Among People Living With HIV/AIDS: A Qualitative Perspective

Overview

Journal J Patient Exp

Specialty Health Services

Date 2019 Jun 26

PMID 31236449

Citations 6

Authors

Syed Imran Ahmed

Maryam Farooqui

Syed Azhar Syed Sulaiman

Mohamed Azmi Hassali

Christopher K C Lee

Affiliations

Soon will be listed here.

Abstract

Background: It is widely accepted that for HIV-positive persons on highly active antiretroviral treatment, high levels of adherence to treatment regimens are essential for promoting viral suppression and preventing drug resistance.

Objectives: This qualitative study examines factors affecting the adherence to HIV/AIDS treatment among patients with HIV/AIDS at a local hospital in Malaysia.

Methods: The data from purposefully selected patients were collected by in-depth interviews using a pretested interview guide. Saturation was reached at the 13th interview. All interviews were audio-taped and transcribed verbatim for analysis using thematic content analysis.

Results: Fear and stigma of perceived negative image of HIV diagnosis, lack of disease understating, poor support from the community, and perceived severity or the treatment side effects were among the reasons of nonadherence. Appropriate education and motivation from the doctors and reduction in pill burden were suggested to improve adherence.

Conclusion: Educational interventions, self-management, and peer and community supports were among the factors suggested to improve adherence. This necessitates uncovering efficient ways to boost doctor-patient communication and recognizing the role of support group for the social and psychological well-being of the patients.

Citing Articles

Experiences of people living with HIV in low- and middle-income countries and their perspectives in self-management: a meta-synthesis.

Dadi T, Wiemers A, Tegene Y, Medhin G, Spigt M AIDS Res Ther. 2024; 21(1):7.

PMID: 38297363 PMC: 10829476. DOI: 10.1186/s12981-024-00595-7.

The Psychosocial Profile of Women Who Defaulted Option B+ HIV Treatment: An Interpretive Phenomenological Analysis Study.

Dhlakama P, Lelaka C, Mavhandu-Mudzusi A HIV AIDS (Auckl). 2023; 15:583-598.

PMID: 37795258 PMC: 10545953. DOI: 10.2147/HIV.S401336.

Factors associated with antiretroviral therapy adherence among adolescents living with HIV in the era of isoniazid preventive therapy as part of HIV care.

Villiera J, Katsabola H, Bvumbwe M, Mhango J, Khosa J, Silverstein A PLOS Glob Public Health. 2023; 2(6):e0000418.

PMID: 36962329 PMC: 10022349. DOI: 10.1371/journal.pgph.0000418.

How the Term 'Self-Management' is Used in HIV Research in Low- and Middle-Income Countries: A Scoping Review.

Davis V, Nixon S, Murphy K, Cameron C, Bond V, Hanass-Hancock J AIDS Behav. 2022; 26(10):3386-3399.

PMID: 35429310 DOI: 10.1007/s10461-022-03668-8.

Development and external validation of a risk calculator to predict internalising symptoms among Ugandan youths affected by HIV.

Brathwaite R, Ssewamala F, Neilands T, Nabunya P, Byansi W, Damulira C Psychiatry Res. 2021; 302:114028.

PMID: 34129997 PMC: 8277696. DOI: 10.1016/j.psychres.2021.114028.

References

Montessori V, Press N, Harris M, Akagi L, Montaner J . Adverse effects of antiretroviral therapy for HIV infection. CMAJ. 2004; 170(2):229-38. PMC: 315530. View

Schnipper J, Kirwin J, Cotugno M, Wahlstrom S, Brown B, Tarvin E . Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006; 166(5):565-71. DOI: 10.1001/archinte.166.5.565. View

Safren S, Kumarasamy N, Hosseinipour M, Harwood M, Hoffman I, McCauley M . Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India. AIDS Behav. 2006; 10(4):443-50. DOI: 10.1007/s10461-006-9094-6. View

Graham J, Bennett I, Holmes W, Gross R . Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. AIDS Behav. 2006; 11(3):385-92. DOI: 10.1007/s10461-006-9164-9. View

Mills E, Nachega J, Bangsberg D, Singh S, Rachlis B, Wu P . Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006; 3(11):e438. PMC: 1637123. DOI: 10.1371/journal.pmed.0030438. View

Vervoort S, Borleffs J, Hoepelman A, Grypdonck M . Adherence in antiretroviral therapy: a review of qualitative studies. AIDS. 2007; 21(3):271-81. DOI: 10.1097/QAD.0b013e328011cb20. View

Battaglioli-DeNero A . Strategies for improving patient adherence to therapy and long-term patient outcomes. J Assoc Nurses AIDS Care. 2007; 18(1 Suppl):S17-22. DOI: 10.1016/j.jana.2006.11.020. View

Horne R, Cooper V, Gellaitry G, Date H, Fisher M . Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr. 2007; 45(3):334-41. DOI: 10.1097/QAI.0b013e31806910e3. View

de Padua C, Cesar C, Bonolo P, Acurcio F, Guimaraes M . Self-reported adverse reactions among patients initiating antiretroviral therapy in Brazil. Braz J Infect Dis. 2007; 11(1):20-6. DOI: 10.1590/s1413-86702007000100007. View

10.

Tong A, Sainsbury P, Craig J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349-57. DOI: 10.1093/intqhc/mzm042. View

11.

Starks H, Trinidad S . Choose your method: a comparison of phenomenology, discourse analysis, and grounded theory. Qual Health Res. 2007; 17(10):1372-80. DOI: 10.1177/1049732307307031. View

12.

Martin L, Williams S, Haskard K, DiMatteo M . The challenge of patient adherence. Ther Clin Risk Manag. 2008; 1(3):189-99. PMC: 1661624. View

13.

. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008; 372(9635):293-9. PMC: 3130543. DOI: 10.1016/S0140-6736(08)61113-7. View

14.

Watt M, Maman S, Earp J, Eng E, Setel P, Golin C . "It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med. 2009; 68(10):1793-800. PMC: 3530387. DOI: 10.1016/j.socscimed.2009.02.037. View

15.

Minzi O, Irunde H, Moshiro C . HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania. Tanzan J Health Res. 2009; 11(1):5-10. DOI: 10.4314/thrb.v11i1.43243. View

16.

Rudy B, Murphy D, Harris D, Muenz L, Ellen J . Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions. AIDS Patient Care STDS. 2009; 23(3):185-94. PMC: 2856493. DOI: 10.1089/apc.2008.0162. View

17.

Nachega J, Mills E, Schechter M . Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS. 2010; 5(1):70-7. DOI: 10.1097/COH.0b013e328333ad61. View

18.

Almeida R, Vieira A . Evaluation of HIV/AIDS patients' knowledge on antiretroviral drugs. Braz J Infect Dis. 2010; 13(3):183-90. DOI: 10.1590/s1413-86702009000300006. View

19.

Hasanah C, Zaliha A, Mahiran M . Factors influencing the quality of life in patients with HIV in Malaysia. Qual Life Res. 2010; 20(1):91-100. DOI: 10.1007/s11136-010-9729-y. View

20.

Nozaki I, Dube C, Kakimoto K, Yamada N, Simpungwe J . Social factors affecting ART adherence in rural settings in Zambia. AIDS Care. 2011; 23(7):831-8. PMC: 3144480. DOI: 10.1080/09540121.2010.542121. View